OXFORD, England, Sept. 3, 2024 /PRNewswire/ -- Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has been…
VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces…
Understanding the risks of uncontrolled LDL cholesterol MISSION, Kan., Aug. 28, 2024 /PRNewswire/ -- (Family Features) Millions of Americans are…
The global heart attack diagnostics market is experiencing growth due to several factors such as increase in prevalence of cardiovascular diseases,…
Continued Clinical and Regulatory Progress on the HeartBeam AIMIGo™ System Enrollment Complete in VALID-ECG Clinical Study That Will Be the…
For the eighth consecutive year, the analytics underpinning the company's proprietary Health Insights Dashboard™ have been recognized for their quality and…
Garvan Institute's TenK10K Project Aims to Map 50 Million Human Cells from 10,000 People PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/…
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and…
“There were no patient deaths or missed episodes requiring external rescue, and high patient compliance enabled a high number of…
Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes…